Colon News and Research

RSS

Researchers show how a new drug speeds tissue regeneration in animal models

The concept sounds like the stuff of science fiction: take a pill, and suddenly new tissues grow to replace damaged ones. Researchers at Case Western Reserve and UT Southwestern Medical Center this week announced that they have taken significant steps toward turning this once-improbable idea into a vivid reality.

12 Jun 2015

Lung cancer patients with comorbid conditions face higher risk of death

Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure had a higher risk of death than lung cancer patients without comorbid conditions, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

12 Jun 2015

Daily dose of aspirin effective at blocking breast tumor growth

"Take two aspirin and call me in the morning" has been the punchline for countless jokes. Could it also be good advice for cancer patients? A lab study to appear in the July 2015 issue of Laboratory Investigation found that a daily dose of aspirin was effective at blocking breast tumor growth. Previous studies have already shown a similar effect on colon, gastrointestinal, prostate, and other cancers.

12 Jun 2015

Study identifies unique bacterial signature in people with systemic sclerosis

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that people with systemic sclerosis (SSc) have a unique bacterial signature in their colon, when compared with healthy people.

12 Jun 2015

Innovative QI program speeds recovery in patients undergoing colon and rectal operations

Patients undergoing colon and rectal operations who participated in an innovative quality improvement (QI) program to speed their recovery and enhance results experienced shorter hospitalizations, reduced infection rates, and lower hospital costs, according to new study results.

8 Jun 2015

Research shows how social network analysis can help identify cancer biomarkers

The advent of online social networks has led to the rapid development of tools for understanding the interactions between members of the network, their activity, the connections, the hubs and nodes. But, any relationships between lots of entities, whether users of Facebook and Twitter, bees in a colony, birds in a flock, or the genes and proteins in our bodies can be analyzed with the same tools.

5 Jun 2015

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

Frisbie Memorial Hospital is now using low-dose CT scanning as a follow-up tool for screening colorectal cancer. This procedure, known as virtual colonoscopy, does not replace the effective and most reliable colorectal cancer screening tool, which is the colonoscopy, but rather it is utilized as a means to obtain additional images of the colon and rectum.

4 Jun 2015

Portable microendoscope could eliminate need for costly biopsies for esophageal cancer patients

In a clinical study of patients in the United States and China, researchers found that a low-cost, portable, battery-powered microendoscope developed by Rice University bioengineers could eventually eliminate the need for costly biopsies for many patients undergoing standard endoscopic screening for esophageal cancer.

3 Jun 2015

PanCuRx initiative to reduce pancreatic cancer fatality rate receives $4.6 million investment from OICR

Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research (OICR) today announced OICR is investing $4.6 million over two years in PanCuRx, an initiative that seeks solutions to the high fatality rate of pancreatic cancer.

1 Jun 2015

People with common form of lung cancer can benefit from nivolumab drug

In a head-to-head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers found that people with squamous-non-small cell lung cancer who received nivolumab lived, on average, 3.2 months longer than those receiving chemotherapy.

1 Jun 2015

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago from May 29-June 2, 2015.

1 Jun 2015

Cancer genetic counselor helps patients make sense of genetics and statistics

Cancer was the second leading cause of death in the United States in 2013 and the American Cancer Society expects almost 10,000 new cases in New Mexico this year.

1 Jun 2015

Mistakes in mismatch repair genes may accurately predict response to certain immunotherapy drugs

In a report of a proof-of-principle study of patients with colon and other cancers for whom standard therapies failed, researchers at the Johns Hopkins Kimmel Cancer Center say that mistakes in so-called mismatch repair genes, first identified by Johns Hopkins and other scientists two decades ago, may accurately predict who will respond to certain immunotherapy drugs known as PD-1 inhibitors. Such drugs aim to disarm systems developed by cancer cells to evade detection and destruction by immune system cells.

30 May 2015

MIT, UCSD researchers use probiotics to detect cancer in the liver

Engineers at MIT and the University of California at San Diego have devised a new way to detect cancer that has spread to the liver, by enlisting help from probiotics — beneficial bacteria similar to those found in yogurt.

29 May 2015

RPCI researchers develop individualized post-operative survival calculator for colon cancer patients

Roswell Park Cancer Institute researchers have developed an accurate, individualized post-operative survival calculator and integrated the technology into a mobile application compatible with smartphone technology for oncologists and patients diagnosed with colon cancer. Information about the calculator will be presented at the American Society of Clinical Oncology 51st Annual Meeting in Chicago.

29 May 2015

Study: New cases of cancer rising globally, but death rates falling in many countries

New cases of virtually all types of cancer are rising in countries globally - regardless of income - but the death rates from cancer are falling in many countries, according to a new analysis of 28 cancer groups in 188 countries.

29 May 2015

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.

28 May 2015

EKF Diagnostics highlighting cancer molecular diagnostics products at ASCO 2015

EKF subsidiary, Selah Genomics’ newly introduced PrecisionPath™ next generation sequencing (NGS) technology cancer test will be a key focus on Booth #19141...

From EKF Diagnostics 28 May 2015

Endomag named finalist for Royal Academy of Engineering's MacRobert Award

Cancer healthcare company Endomag has been revealed as a finalist for the UK’s most prestigious engineering award. Endomag, which was shortlisted for its innovative breast cancer staging diagnostic system Sentimag and Sienna+, is one of three companies up for the MacRobert Award from the Royal Academy of Engineering.

21 May 2015

New research points to potential therapeutic target for treating multiple sclerosis

New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty "brake" within immune cells, a brake that should be controlling the inflammation. This points to a potential target for developing new therapies to treat multiple sclerosis and could have important implications for other autoimmune diseases, such as the colon disease colitis and the chronic skin condition atopic dermatitis.

20 May 2015

Colon News and Research

Researchers show how a new drug speeds tissue regeneration in animal models

Lung cancer patients with comorbid conditions face higher risk of death

Daily dose of aspirin effective at blocking breast tumor growth

Study identifies unique bacterial signature in people with systemic sclerosis

Innovative QI program speeds recovery in patients undergoing colon and rectal operations

Research shows how social network analysis can help identify cancer biomarkers

Frisbie Memorial Hospital now uses low-dose CT scanning for screening colorectal cancer

Portable microendoscope could eliminate need for costly biopsies for esophageal cancer patients

PanCuRx initiative to reduce pancreatic cancer fatality rate receives $4.6 million investment from OICR

People with common form of lung cancer can benefit from nivolumab drug

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

Cancer genetic counselor helps patients make sense of genetics and statistics

Mistakes in mismatch repair genes may accurately predict response to certain immunotherapy drugs

MIT, UCSD researchers use probiotics to detect cancer in the liver

RPCI researchers develop individualized post-operative survival calculator for colon cancer patients

Study: New cases of cancer rising globally, but death rates falling in many countries

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

EKF Diagnostics highlighting cancer molecular diagnostics products at ASCO 2015

Endomag named finalist for Royal Academy of Engineering's MacRobert Award

New research points to potential therapeutic target for treating multiple sclerosis

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News